Rotational Pharmacist

We are seeking motivated pharmacists to join our rotational pharmacist team, delivering high-quality front-line medicines management across University College London Hospitals. You will be supported through our established and continually evolving foundation programme, providing structured training and development. This includes support to build and maintain a portfolio of competence, which will contribute evidence towards the UCL JPB Diploma in General Pharmacy Practice, onto which you will be enrolled.

You will work as an integral member of multidisciplinary teams across a wide range of clinical specialties, contributing to patient care and participating in audit, quality improvement and project work as you progress.

• Excellent communication and customer care skills
• Motivation and the ability to motivate others
• The ability to work effectively both independently and as part of a team
• Good time management and prioritisation skills

University College London Hospitals NHS Foundation Trust (UCLH) is one of the most complex NHS trusts in the UK, serving a large and diverse population. We provide academically led acute and specialist services, to people from the local area, from throughout the United Kingdom and overseas. Our vision is to deliver top-quality patient care, excellent education, and world-class research. We provide first-class acute and specialist services across eight sites:

• University College Hospital (incorporating the Elizabeth Garrett Anderson Wing), We are dedicated to the diagnosis and treatment of many complex illnesses. UCLH specialises in women's health and the treatment of cancer, infection, neurological, gastrointestinal and oral disease. It has world class support services including critical care, imaging, nuclear medicine and pathology.

We are committed to sustainability and have pledged to become a carbon net zero health service, embedding sustainable practice throughout UCLH. We have set an ambitious target of net zero for our direct emissions by 2031 and indirect emissions by 2040.